✨ Free AI Report
Smith & Nephew plc: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Smith & Nephew plc
Company Research

Smith & Nephew plc: Business Overview, Financials & Competitive Analysis

Founded in Hull, UK, in 1856, Smith & Nephew generated annual sales of $5.8 billion in 2024 and operates as a diversified medical technology company. It operates in three segments: Orthopaedics, Sports Medicine & ENT,...

Analyst-debate audio for Smith & Nephew plc

AskCyborg analysts argue the bull and bear cases for Smith & Nephew plc across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Strong

Cyborg Score thesis

Solid operational turnaround with strong mid-market growth trajectory, but execution consistency in 2026 will be critical to...

Read the full analyst-debate transcript →
Industry Medical Devices & Healthcare Technology
4 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Smith & Nephew plc Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Smith & Nephew plc Overview

Pro stress-test →

Founded in Hull, UK, in 1856, Smith & Nephew generated annual sales of $5.8 billion in 2024 and operates as a diversified medical technology company. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management, serving healthcare providers globally with innovative surgical and therapeutic solutions.

Strategic Profile

Pro stress-test →

The company's new RISE framework is designed to accelerate growth, expand margins and improve operational efficiency to strengthen shareholder returns. Smith & Nephew has outperformed peers, driven by strong sports medicine and wound care, despite ongoing ortho business challenges, with management executing a focused turnaround under CEO Deepak Nath.

Competitive Landscape

Pro stress-test →

Smith & Nephew operates in three segments spanning orthopaedics, sports medicine and advanced wound management. Key competitors include Stryker and Zimmer Biomet in orthopaedics, DePuy Synthes (Johnson & Johnson) in trauma, Baxter and Medtronic in wound care, and Arthrex in sports medicine, with the company's competitive advantage centered on innovation-driven portfolio rationalization and margin expansion.

Industry Context

Smith & Nephew plc operates in Medical Devices & Healthcare Technology.

Key facts

Founded: 1856 · Headquarters: Hull, United Kingdom · Employees: 18,000 · Revenue: $5.8B · Market cap: $14.4B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Smith & Nephew plc.

  • 2026 guidance projects around 6% underlying revenue growth, profit growth ahead of sales, and free cash flow of roughly $800 million
  • Portfolio rationalization expected to reduce gross inventory by about $500 million and create a non-cash provision of roughly $200 million in 2025
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • January 2026Acquired Integrity Orthopaedics to expand shoulder repair capabilities
  • December 2025Announced RISE strategy with 2028 targets at Capital Markets Day
  • +2 moreTrack every material event for Smith & Nephew plc as it happens. Explore monitoring →
Get alerted when Smith & Nephew plc has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Stryker Orthopaedic PlatformsLeading orthopaedic and trauma implant manufacturer→Zimmer Biomet Orthopedic PortfolioMajor knee and hip implant competitor→Arthrex Sports MedicineSports medicine and soft tissue repair leader→Medtronic Wound CareAdvanced wound management and therapies→

Compare Smith & Nephew plc with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Smith & Nephew plc operates in Medical Devices & Healthcare Technology. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices & Healthcare Technology research →
NEW · MCP server

Ask your AI assistant about Smith & Nephew plc

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Smith & Nephew plc and its top competitor on Cyborg Score”
“What did Smith & Nephew plc do this quarter?”
“Is Smith & Nephew plc a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Smith & Nephew plc do?+
Founded in Hull, UK, in 1856, Smith & Nephew generated annual sales of $5.8 billion in 2024 and operates as a diversified medical technology company. It operates in three segments: Orthopaedics, Sports Medicine & ENT,...
What is Smith & Nephew plc's Cyborg Score?+
Smith & Nephew plc has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Smith & Nephew plc's main competitors?+
Named competitors include Stryker Orthopaedic Platforms, Zimmer Biomet Orthopedic Portfolio, Arthrex Sports Medicine, Medtronic Wound Care. The full competitive landscape is in the AskCyborg report.
How can I get the full Smith & Nephew plc research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Smith & Nephew plc research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Smith & Nephew plc over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Medical Devices & Healthcare Technology research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Medtronic plc7Koninklijke Philips N.V.7Terumo Corporation